Oncternal Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCT and other ETFs, options, and stocks.

About ONCT

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. 

CEO
James B. Breitmeyer
CEOJames B. Breitmeyer
Employees
26
Employees26
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
26
Employees26

ONCT Key Statistics

Market cap
47.44M
Market cap47.44M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
293.09K
Average volume293.09K
High today
$0.932
High today$0.932
Low today
$0.86
Low today$0.86
Open price
$0.8786
Open price$0.8786
Volume
143.88K
Volume143.88K
52 Week high
$4.49
52 Week high$4.49
52 Week low
$0.6902
52 Week low$0.6902

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

ONCT Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.